Search - tctmd.com

Displaying 581 - 600 of 1037

Sort: Relevancy | Date

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

News Conference News HRS 2020

Permanent Conduction-System Pacing After TAVR? Don’t ‘Diss the His’

Michael O'Riordan

May 21, 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

News Conference News SCAI 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

May 20, 2020

PRECEPT Provides Support for Ablation of Symptomatic, Persistent A-fib

News Conference News HRS 2020

PRECEPT Provides Support for Ablation of Symptomatic, Persistent A-fib

May 15, 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

News Conference News HRS 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

May 13, 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

April 02, 2020

Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO

News Conference News ACC 2020

Ischemia Burden Not Linked to Angina in Nonobstructive CAD: CIAO

Michael O'Riordan

March 31, 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA

News Conference News ACC 2020

Anatomic Burden, Ischemia Severity, and Outcomes in ISCHEMIA

March 29, 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

News Conference News ACC 2020

A Win for Vericiguat in High-Risk Chronic HF Patients: VICTORIA

Michael O'Riordan

March 28, 2020

Hypertension-Related CV Deaths Surging Across the US

News Conference News ACC 2020

Hypertension-Related CV Deaths Surging Across the US

March 24, 2020

Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity

News Conference News ACC 2020

Statins May Have Protective Effect on Chemotherapy-Induced Cardiotoxicity

Yael L. Maxwell

March 19, 2020

Hospital MV Surgical Volume Not Tied to TMVr Outcomes

News Conference News ACC 2020

Hospital MV Surgical Volume Not Tied to TMVr Outcomes

March 19, 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

News Conference News CRT 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

February 27, 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

February 25, 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

News Conference News CRT 2020

Meta-analysis Upholds Complete PCI in STEMI, as Thoughts Turn to Timing, Costs

Michael O'Riordan

February 24, 2020

Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It?

News Conference News ISC 2020

Another Neuroprotective Agent Fails in Acute Stroke . . . Or Does It?

February 21, 2020

Safer, Quicker Discharge With Protocols for Enhanced Recovery After Surgery

News Conference News STS 2020

Safer, Quicker Discharge With Protocols for Enhanced Recovery After Surgery

Yael L. Maxwell

February 07, 2020

Age-Old Debate: When Does the Senior Surgeon Put the Scalpel Away?

News Conference News STS 2020

Age-Old Debate: When Does the Senior Surgeon Put the Scalpel Away?

Yael L. Maxwell

February 06, 2020

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

News Conference News PCR London Valves 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

News Conference News PCR London Valves 2019

Durable 1-Year Results with TriClip Edge-to-Edge Repair for TR: TRILUMINATE

Michael O'Riordan

November 25, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.